Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-25

Clinical Trial Update: Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test [Phase 4]

View source ↗

Summary

Phase 4 trial updating the safety result of Cetaphil Daily Facial Moisturizer with SPF 50+ in a human repeat insult patch test for skin irritation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetaphil Daily Facial Moisturizer with Sunscreen SPF 50+

Snippet

Sponsor: Galderma R&D | Conditions: Skin Irritation | Phase 4 | Status: COMPLETED | Results posted: 2013-09-25